These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6681710)

  • 1. Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):87S-95S. PubMed ID: 6681710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ
    J Mol Cell Cardiol; 1984 Jul; 16(7):633-41. PubMed ID: 6433026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(3):406-17. PubMed ID: 6191139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a thromboxane synthetase inhibitor, Y-20811, on infarct size, neutrophil accumulation, and arrhythmias after coronary artery occlusion and reperfusion in dogs.
    Sato N; Endo T; Kiuchi K; Hayakawa H
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):353-61. PubMed ID: 7681494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1984 Apr; 81(4):675-84. PubMed ID: 6547068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a thromboxane synthetase inhibitor in circumflex coronary artery occlusion and reperfusion.
    Huddleston CB; Lupinetti FM; Clanton J; Collins J; Oates JA; Hammon JW
    Curr Surg; 1983; 40(3):211-5. PubMed ID: 6683615
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs.
    Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M
    Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(4):557-67. PubMed ID: 6193351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    VĂ©gh A; Parratt JR
    Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1985 Sep; 86(1):259-64. PubMed ID: 3840397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of beta-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischemia.
    Wainwright CL; Parratt JR
    Adv Myocardiol; 1985; 6():573-84. PubMed ID: 4039460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of thromboxane synthesis during experimental endotoxemia in the goat: effects on pulmonary haemodynamics and lung lymph flow.
    Harlan J; Winn R; Hildebrandt J; Harker L
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):123S-126S. PubMed ID: 6337602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    J Mol Cell Cardiol; 1984 Jan; 16(1):43-52. PubMed ID: 6366241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on "The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs".
    Crampton RS; Kaiser DL
    Circ Res; 1984 Apr; 54(4):474-5. PubMed ID: 6538818
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
    Imamoto T; Terashita Z; Tanabe M; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1986; 8(4):832-9. PubMed ID: 2427826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.